News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,505 Results
Type
Article (41569)
Company Profile (463)
Press Release (658473)
Section
Business (208385)
Career Advice (2002)
Deals (35940)
Drug Delivery (92)
Drug Development (83284)
Employer Resources (169)
FDA (16325)
Job Trends (15043)
News (352058)
Policy (32976)
Tag
Academia (2619)
Alliances (50582)
Alzheimer's disease (1270)
Approvals (16245)
Artificial intelligence (134)
Bankruptcy (361)
Best Places to Work (11727)
Biotechnology (349)
Breast cancer (120)
Cancer (1064)
Cardiovascular disease (90)
Career advice (1671)
Cell therapy (236)
Clinical research (65880)
Collaboration (385)
Compensation (190)
COVID-19 (2588)
C-suite (92)
Data (1060)
Diabetes (154)
Diagnostics (6190)
Earnings (86022)
Employer resources (147)
Events (112795)
Executive appointments (285)
FDA (16838)
Funding (344)
Gene therapy (185)
GLP-1 (608)
Government (4407)
Healthcare (18990)
Infectious disease (2670)
Inflammatory bowel disease (111)
Interviews (308)
IPO (16560)
Job creations (3694)
Job search strategy (1428)
Layoffs (439)
Legal (7926)
Lung cancer (169)
Manufacturing (175)
Medical device (13317)
Medtech (13322)
Mergers & acquisitions (19427)
Metabolic disorders (414)
Neuroscience (1541)
NextGen Class of 2024 (6733)
Non-profit (4531)
Northern California (1432)
Obesity (240)
Opinion (197)
Patents (99)
People (57562)
Phase I (20637)
Phase II (29079)
Phase III (21513)
Pipeline (445)
Postmarket research (2590)
Preclinical (8861)
Radiopharmaceuticals (250)
Rare diseases (221)
Real estate (5997)
Regulatory (21932)
Research institute (2403)
Resumes & cover letters (351)
Southern California (1287)
Startups (3745)
United States (13429)
Vaccines (564)
Weight loss (181)
Date
Last 7 days (935)
Last 30 days (3525)
Last 365 days (36474)
2024 (33080)
2023 (41013)
2022 (52276)
2021 (56765)
2020 (54924)
2019 (47419)
2018 (35697)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (731)
Arizona (198)
Asia (38475)
Australia (6395)
California (3281)
Canada (1261)
China (241)
Colorado (145)
Connecticut (153)
Europe (83912)
Florida (441)
Georgia (112)
Illinois (349)
Indiana (193)
Kansas (99)
Maryland (581)
Massachusetts (2642)
Michigan (155)
Minnesota (274)
New Jersey (938)
New York (942)
North Carolina (747)
Northern California (1432)
Ohio (135)
Pennsylvania (824)
South America (1105)
Southern California (1287)
Texas (450)
Utah (90)
Washington State (365)
700,505 Results for "nammi therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nammi Therapeutics, Inc. Announces First Patient Dosed with QXL138AM in a Phase 1 Study Evaluating Advanced Solid Tumors and Multiple Myeloma
November 8, 2024
·
2 min read
Press Releases
Nammi Therapeutics, Inc. Completes Series B Round with Investment from MMRF’s Myeloma Investment Fund; Advances Clinical Development of Lead Program, QXL138AM
August 6, 2024
·
4 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Biotech Bay
Amgen and Biolabs LA at the Lundquist Institute Announce Nammi Therapeutics to Receive the Third Amgen Golden Ticket
Amgen and BioLabs LA at The Lundquist Institute announced that Nammi Therapeutics has been awarded the third Amgen Golden Ticket in Southern California.
January 6, 2023
·
5 min read
Biotech Beach
Nammi Therapeutics Granted FDA Orphan Drug Designation For QXL138AM for the Treatment of Multiple Myeloma
Nammi Therapeutics, Inc. (Nammi), an LA-based immunotherapy company, announced today that the US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to its lead program, QXL138AM, for the treatment of multiple myeloma.
June 13, 2022
·
2 min read
Policy
Nammi Therapeutics Granted FDA Orphan Drug Designation For QXL138AM for the Treatment of Pancreatic Cancer
Nammi Therapeutics, Inc., a Los Angeles based immunotherapy company, announced that the US Food and Drug Administration has granted orphan drug designation to its lead program, QXL138AM, for the treatment of Pancreatic Cancer.
June 16, 2022
·
2 min read
Press Releases
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
November 13, 2024
·
4 min read
Business
Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
Gain Therapeutics, Inc. announces that Matthias Alder has departed the Company in order to pursue other opportunities.
June 27, 2024
·
5 min read
Press Releases
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
October 8, 2024
·
14 min read
Press Releases
ReCerise Therapeutics Inc. Selected for Government Project by MOTIE
Initiates Development of Tailored Innovative Targeted Therapy for Refractory Cancer ReCerise Therapeutics Inc., has announced its selection for a grant from the Ministry of Trade, Industry and Energy of South Korea.
July 1, 2024
·
2 min read
1 of 70,051
Next
